Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector

Human Gene Therapy

Volumn 11, Issue 3, 2000, Pages 379-388

  Sauthoff, Harald ^a   Heitner, Sheila ^a   Rom, William N ^a   Hay, John G ^a,b  

^a Division of Pulmonary Critical Care and Sleep Medicine   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL; PROTEIN; VIRUS VECTOR;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; PHENOTYPE; TUMOR CELL; VIRUS GENE;

ADENOVIRIDAE; ADENOVIRUS E1B PROTEINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; GENE DELETION; GENETIC VECTORS; HUMANS; PACLITAXEL; PLAQUE ASSAY; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

ADENOVIRIDAE; DNA VIRUSES;

EID: 0034628552     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050015851     Document Type: Article

References (47)

1. BABISS, L.E., and GINSBERG, H.S. (1984). Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis. J. Virol. 50, 202-212.
2. BARRY, M.A., BEHNKE, C.A., and EASTMAN, A. (1990). Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40, 2353-2362.
3. BECK, W., CASS, C., and HOUGHTON, P. (1997). Anticancer drugs from plants: Vinca alkaloids and taxanes. In Cancer Medicine, 4th Ed., Vol. 1. J. Holland, R. Bast, D. Morton, E. Frei III, D. Kufe, and R. Weichelbaum, eds. (Williams & Wilkins, Baltimore, MD) pp. 1005-1026.
4. BISCHOFF, J., KIRN, D., WILLIAMS, A., HEISE, C., HORN, S., MUNA, M., NG, L., NYE, J., SAMPSON-JOHANNES, A., FATTAEY, A., and MCCORMICK, F. (1996). An adenovirus mutant that replicates selectively in p53 deficient human tumor cells. Science 274, 373-376.
5. CHEN, G., BRANTON, P.E., YANG, E., KORSMEYER, S.J., and SHORE, G.C. (1996). Adenovirus E1B 19-kDa death suppressor protein interacts with Bax but not with Bad. J. Biol. Chem. 271, 24221-24225.
6. CHINNADURAI, G. (1983). Adenovirus 2 Ip+ locus codes for a 19 kd tumor antigen that plays an essential role in cell transformation. Cell 33, 759-766.
7. CHIOU, S.K., and WHITE, E. (1998). Inhibition of ICE-like proteases inhibits apoptosis and increases virus production during adenovirus infection. Virology 244, 108-118.
8. CHIOU, S.K., TSENG, C.C., RAO, L., and WHITE, E. (1994). Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68, 6553-6566.
9. COLVIN, O. (1997). Alkylating agents and platinum antitumor compounds. In Cancer Medicine, 4th Ed., Vol. 1. J. Holland, R. Bast, D. Morton, E. Frei III, D. Kufe, and R. Weichelbaum, eds. (William & Wilkins, Baltimore, MD) pp. 949-976.
10. DEBBAS, M., and WHITE, E. (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7, 546-554.
11. GOODRUM, F.D., and ORNELLES, D.A. (1998). p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection. J. Virol. 72, 9479-9490.
12. HALL, A.R., DIX, B.R., O'CARROLL, S.J., and BRAITHWAITE, A.W. (1998). p53-dependent cell death/apoptosis is required for a productive adenoviral infection. Nature Med. 4, 1068-1072.
13. HAN, J., SABBATINI, P., PEREZ, D., RAO, L., MODHA, D., and WHITE, E. (1996a). The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10, 461-477.
14. HAN, J., SABBATINI, P., and WHITE, E. (1996b). Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16, 5857-5864.
15. HARADA, J.N., and BERK, AJ. (1999). p53-independent and -dependent requirements for E1B-55K in adenovirus type 5 replication. J. Virol. 73, 5333-5344.
16. HAY, J., SHAPIRO, N., SAUTOFF, H., HEITNER, S., PHUPAKDI, W., and ROM, W. (1999). Targeting the replication of adenoviral gene therapy vectors to lung cancer cells - the importance of the adenoviral E1b-55kD gene. Hum. Gene Ther. 10, 579-590.
17. HEISE, C., SAMPSON-JOHANNES, A., WILLIAMS, A., MCCORMICK, F., VON HOFF, D.D., and KIRN, D.H. (1997). ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nature Med. 3, 639-645.
18. HEISE, C.C., WILLIAMS, A.M., XUE, S., PROPST, M., and KIRN, D.H. (1999). Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy. Cancer Res. 59, 2623-2628.
19. HU, M.C., and HSU, M.T. (1997). Adenovirus E1B 19K protein is required for efficient DNA replication in U937 cells. Virology 227, 295-304.
20. IMAI, Y., KIMURA, T., MURAKAMI, A., YAJIMA, N., SAKAMAKI, K., and YONEHARA, S. (1999). The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature (London) 398, 777-785.
21. MITTEREDER, N., MARCH, K.L., and TRAPNELL, B.C. (1996). Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498-7509.
22. PEREZ, D., and WHITE, E. (1998). E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE. J. Cell Biol. 141, 1255-1266.
23. PILDER, S., LOGAN, J., and SHENK, T. (1984). Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA. J. Virol. 52, 664-671.
24. RAO, L., DEBBAS, M., SABBATINI, P., HOCKENBERY, D., KORSMEYER, S., and WHITE, E. (1992). The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. U.S.A. 89, 7742-7746.
25. RODRIGUEZ, R., SCHUUR, E.R., LIM, H.Y., HENDERSON, G.A., SIMONS, J.W., and HENDERSON, D.R. (1997). Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57, 2559-2563.
26. ROTHMANN, T., HENGSTERMANN, A., WHITAKER, N.J., SCHEFFNER, M., and ZUR HAUSEN, H. (1998). Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol. 72, 9470-9478.
27. SABBATINI, P., CHIOU, S.K., RAO, L., and WHITE, E. (1995). Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol. 15, 1060-1070.
28. SETHI, T., RINTOUL, R.C., MOORE, S.M., MACKINNON, A.C., SALTER, D., CHOO, C., CHILVERS, E.R., DRANSFIELD, I., DONNELLY, S.C., STRIETER, R., and HASLETT, C. (1999). Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Med. 5, 662-668.
29. SHENK, T., and FLINT, J. (1991). Transcriptional and transforming activities of the adenovirus E1A proteins. Adv. Cancer Res. 57, 47-85.
30. SORENSON, C.M., BARRY, M.A., and EASTMAN, A. (1990). Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J. Natl. Cancer Inst. 82, 749-755.
31. SUBRAMANIAN, T., KUPPUSWAMY, M., GYSBERS, J., MAK, S., and CHINNADURAI, G. (1984a). 19-kDa tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA. J. Biol. Chem. 259, 11777-11783.
32. SUBRAMANIAN, T., KUPPUSWAMY, M., MAK, S., and CHINNADURAI, G. (1984b). Adenovirus cyt+ locus, which controls cell transformation and tumorigenicity, is an allele of 1p+ locus, which codes for a 19-kilodalton tumor antigen. J. Virol. 52, 336-343.
33. SUBRAMANIAN, T., TARODI, B., GOVINDARAJAN, R., BOYD, J.M., YOSHIDA, K., and CHINNADURAI, G. (1993). Mutational analysis of the transforming and apoptosis suppression activities of the adenovirus E1B 175R protein. Gene 124, 173-181.
34. TAKEMORI, N., CLADARAS, C., BHAT, B., CONLEY, A.J., and WOLD, W.S. (1984). cyt gene of adenoviruses 2 and 5 is an oncogene for transforming function in early region E1B and encodes the E1B 19,000-molecular-weight polypeptide. J. Virol. 52, 793-805.
35. TELLING, G.C., PERERA, S., SZATKOWSKI-OZERS, M., and WILLIAMS, J. (1994). Absence of an essential regulatory influence of the adenovirus E1B 19-kilodalton protein on viral growth and early gene expression in human diploid WI38, HeLa, and A549 cells. J. Virol. 68, 541-547.
36. TURNELL, A.S., GRAND, R.J., and GALLIMORE, P.H. (1999). The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status. J. Virol. 73, 2074-2083.
37. WHITE, E. ( 1995). Regulation of p53-dependent apoptosis by E1A and E1B. Curr. Top. Microbiol. Immunol. 199, 34-58.
38. WHITE, E. (1998). Regulation of apoptosis by adenovirus E1A and E1B oncogenes. Semin. Virol. 8, 505-513.
39. WHITE, E., and STILLMAN, B. (1987). Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins. J. Virol. 61, 426-435.
40. WHITE, E., GRODZICKER, T., and STILLMAN, B.W. (1984). Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA. J. Virol. 52, 410-419.
41. WHITE, E., DENTON, A., and STILLMAN, B. (1988). Role of the adenovirus E1B 19,000-dalton tumor antigen in regulating early gene expression. J. Virol. 62, 3445-3454.
42. WHITE, E., CIPRIANI, R., SABBATINI, P., and DENTON, A. (1991). Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65, 2968-2978.
43. WHITE, E., SABBATINI, P., DEBBAS, M., WOLD, W.S., KUSHER, D.I., and GOODING, L.R. (1992). The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell. Biol. 12, 2570-2580.
44. WILDNER, O., BLAESE, R.M., and MORRIS, J.C. (1999a). Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase. Cancer Res. 59, 410-413.
45. WILDNER, O., MORRIS, J.C., VAHANIAN, N.N., FORD, H., JR., RAMSEY, W.J., and BLAESE, R.M. (1999b). Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer. Gene Ther. 6, 57-62.
46. WORGALL, S., WOLFF, G., FALCK-PEDERSEN, E., and CRYSTAL, R.G. (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8, 37-44.
47. ZAFFARONI, N., SILVESTRINI, R., ORLANDI, L., BEARZATTO, A., GORNATI, D., and VILLA, R. (1998). Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells. Br. J. Cancer 77, 1378-1385.